N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen, Kathleen K. Brown, Jeff E. Cobb, Jon L. Collins, W. Wallace Harrington, Mir A. Hashim, Emily A. Hull-Ryde, Istvan Kaldor, Steven A. Kliewer, Debra H. Lake, Lisa M. Leesnitzer, Jürgen M. Lehmann, James M. Lenhard, Lisa A. Orband-Miller, John F. Miller, Robert A. Mook, Stewart A. Noble, William OliverDerek J. Parks, Kelli D. Plunket, Jerzy R. Szewczyk, Timothy M. Willson

Research output: Contribution to journalArticlepeer-review

279 Scopus citations

Fingerprint Dive into the research topics of 'N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds